Swati Rathore
Overview
Explore the profile of Swati Rathore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varunashree N, Daniel S, Rathore S, Moorthy M, Yadav B, Beck M
J Family Med Prim Care
. 2025 Jan;
13(12):5512-5517.
PMID: 39790786
Objectives: To study the rates of abnormal placentae and associated adverse perinatal outcomes in pregnant women who had COVID 19 infection during pregnancy, remote from delivery. To study the histopathological...
2.
Gifty D, Cherian N, Raj S, Yenuberi H, Rathore S, Mathews J
J Family Med Prim Care
. 2024 Dec;
13(10):4499-4504.
PMID: 39629413
Context: Over-medicalization of normal pregnancy is associated with unnecessary inductions of labor leading to operative deliveries. In a busy outpatient department (OPD) or low-resource setup where ultrasound availability, experience, and...
3.
Reddy T, Nirupama S, Raj A, Tirkey R, Yenuberi H, Mahasampath G, et al.
J Family Med Prim Care
. 2024 Oct;
13(9):3850-3855.
PMID: 39464931
Context: The prevalence of gestational diabetes mellitus (GDM) in the Indian subcontinent has increased exponentially, especially after new diagnostic criteria. Identifying women who need close monitoring is a challenge. Ultrasound...
4.
Rai N, Tiwari R, Sahu A, Verma E, Rathore S, Patil S, et al.
Anticancer Agents Med Chem
. 2024 Sep;
25(2):124-133.
PMID: 39297455
Background: Ultra-short peptides are essential therapeutic agents due to their heightened selectivity and reduced toxicity. Scientific literature documents the utilization of dipeptides, tripeptides, and tetrapeptides as promising agents for combating...
5.
Gadekar V, Damaraju N, Xavier A, Thakur S, Vijayram R, Desiraju B, et al.
Lancet Reg Health Southeast Asia
. 2024 Jul;
25:100362.
PMID: 39021476
Background: A large proportion of pregnant women in lower and middle-income countries (LMIC) seek their first antenatal care after 14 weeks of gestation. While the last menstrual period (LMP) is...
6.
Agarwala P, Raghav M, Rathore S, Gupta A, Mehrol C
Indian J Pathol Microbiol
. 2024 Feb;
67(2):479-480.
PMID: 38391372
No abstract available.
7.
Yenuberi H, Ross B, Sasmita Tirkey R, Benjamin S, Rathore S, Karuppusami R, et al.
Obstet Gynecol
. 2024 Feb;
143(4):468-474.
PMID: 38330411
Objective: To evaluate the efficacy of antenatal corticosteroids in reducing neonatal respiratory complications when administered to those at risk of preterm delivery between 34 and 36 6/7 weeks of gestation....
8.
Blossia S, Sasmita Tirkey R, Kingsbury B, Yenuberi H, Mahasampath G, Jude J, et al.
J Family Med Prim Care
. 2023 Jul;
12(5):953-957.
PMID: 37448938
Background: There is a very little information known about CRP in term pregnancies. It is a marker that is easily tested and is inexpensive. Although CRP has been used very...
9.
Yenuberi H, Mathews J, George A, Benjamin S, Rathore S, Tirkey R, et al.
Int J Gynaecol Obstet
. 2023 Jul;
164(2):482-498.
PMID: 37401143
Background: Misoprostol is widely used for cervical ripening and labour induction as it is heat-stable and inexpensive. Oral misoprostol 25 μg given 2-hourly is recommended over vaginal misoprostol 25 μg...
10.
R G, Pricilla R, Kurian S, Benjamin S, Rathore S, Yenuberi H, et al.
BMJ Open
. 2022 Dec;
12(12):e063497.
PMID: 36535722
Introduction: In a large developing country, with diverse population characteristics and differential access to healthcare, it is important to identify factors that influence postnatal health. This knowledge will help frame...